|
HY-15084A-10mg
|
MedChemexpress LLC
|
(-)-Dizocilpine (maleate) [CAS 121917-57-5]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-15084A-100mg
|
MedChemexpress LLC
|
(-)-Dizocilpine (maleate) [CAS 121917-57-5]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-15084A-5mg
|
MedChemexpress LLC
|
(-)-Dizocilpine (maleate) [CAS 121917-57-5]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-15084A-50mg
|
MedChemexpress LLC
|
(-)-Dizocilpine (maleate) [CAS 121917-57-5]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-15084A-1mL
|
MedChemexpress LLC
|
(-)-Dizocilpine (maleate) [CAS 121917-57-5] (10mM in DMSO)
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-17387-10mg
|
MedChemexpress LLC
|
(-)-Huperzine A [CAS 102518-79-6]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-17387-100mg
|
MedChemexpress LLC
|
(-)-Huperzine A [CAS 102518-79-6]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-17387-200mg
|
MedChemexpress LLC
|
(-)-Huperzine A [CAS 102518-79-6]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-17387-5mg
|
MedChemexpress LLC
|
(-)-Huperzine A [CAS 102518-79-6]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-17387-50mg
|
MedChemexpress LLC
|
(-)-Huperzine A [CAS 102518-79-6]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-17387-1mL
|
MedChemexpress LLC
|
(-)-Huperzine A [CAS 102518-79-6] (10mM in DMSO)
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-123352A-10mg
|
MedChemexpress LLC
|
(-)-ZK 216348
|
|
|
|
|
HY-123352A-100mg
|
MedChemexpress LLC
|
(-)-ZK 216348
|
|
|
|
|
HY-123352A-25mg
|
MedChemexpress LLC
|
(-)-ZK 216348
|
|
|
|
|
HY-123352A-5mg
|
MedChemexpress LLC
|
(-)-ZK 216348
|
|
|
|
|
HY-123352A-50mg
|
MedChemexpress LLC
|
(-)-ZK 216348
|
|
|
|
|
HY-13030-1g
|
MedChemexpress LLC
|
(+)-JQ-1 [CAS 1268524-70-4]
|
|
Cancer-programmed cell death
|
|
|
HY-13030-10mg
|
MedChemexpress LLC
|
(+)-JQ-1 [CAS 1268524-70-4]
|
|
Cancer-programmed cell death
|
|
|
HY-13030-100mg
|
MedChemexpress LLC
|
(+)-JQ-1 [CAS 1268524-70-4]
|
|
Cancer-programmed cell death
|
|
|
HY-13030-2mg
|
MedChemexpress LLC
|
(+)-JQ-1 [CAS 1268524-70-4]
|
|
Cancer-programmed cell death
|
|
|
HY-13030-5mg
|
MedChemexpress LLC
|
(+)-JQ-1 [CAS 1268524-70-4]
|
|
Cancer-programmed cell death
|
|
|
HY-13030-50mg
|
MedChemexpress LLC
|
(+)-JQ-1 [CAS 1268524-70-4]
|
|
Cancer-programmed cell death
|
|
|
HY-13030-500mg
|
MedChemexpress LLC
|
(+)-JQ-1 [CAS 1268524-70-4]
|
|
Cancer-programmed cell death
|
|
|
HY-13030-1mL
|
MedChemexpress LLC
|
(+)-JQ-1 [CAS 1268524-70-4] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-112789-10mg
|
MedChemexpress LLC
|
(+)-JQ1 PA [CAS 2115701-93-2]
|
|
Cancer-programmed cell death
|
|
